QIAGEN Plans $300 Million Return to Shareholders via Synthetic Share Buyback

QIAGEN N.V. announced its intention to return approximately $300 million to shareholders through a synthetic share repurchase. This decision was supported unanimously at the Annual General Meeting in June 2024. The approach combines a direct capital repayment with a reverse stock split, enhancing earnings per share (EPS) by reducing the number of outstanding shares. The process is set to be effective as of January 28, 2025.

The synthetic share repurchase comprises three steps. First, the par value of shares is increased using the Share Premium Reserve. Second, a reverse stock split consolidates the shares. Finally, the par value returns to its original level, with capital repayment issued directly to shareholders in accordance with market standards. Further details will be disclosed prior to implementation.